Construction and efficacy test of a survival prediction model for locally advanced cervical cancer based on anti-angiogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Construction and efficacy test of a survival prediction model for locally advanced cervical cancer based on anti-angiogenesis

Published:2024-06 Issue: Volume:297 Page:72-77
ISSN:0301-2115
Container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
language:en
Short-container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology

Author:

luo Yuanyuan,ma Xiaojie^ORCID

Publisher

Elsevier BV

Reference22 articles.

1. Cancer of the cervix uteri: 2021 update;Bhatla;Int. J. Gynaecol. Obstet.,2021

2. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer;Mayadev;Int. J. Gynecol. Cancer,2022

3. Anti-angiogenic therapy: current challenges and future perspectives;Lopes-Coelho;Int. J. Mol. Sci.,2021

4. Molecular mechanism of VEGF and its role in pathological angiogenesis;Ahmad;J. Cell. Biochem.,2022

5. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment;Liu;Cell Prolif.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP